-transparent.png){kind=logo}
A 53-year-old woman with Nelson's syndrome was treated with 600 mg sodium valproate daily. Her plasma ACTH was effectively decreased, whilst the response of plasma ACTH to corticotrophin-releasing factor (CRF) was unaltered. The result of the CRF test suggested that sodium valproate, at least in the present patient, acted at the hypothalamic level.
Related Publications
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
March 1983,
The Journal of endocrinology,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
January 1989,
Virchows Archiv. B, Cell pathology including molecular pathology,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
January 1986,
Neuroendocrinology,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
November 1997,
Journal of reproduction and fertility,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
August 1984,
The Journal of endocrinology,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
February 1988,
Clinical endocrinology,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
March 1996,
The Journal of endocrinology,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
January 1987,
Hormone research,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
November 1981,
The Journal of clinical endocrinology and metabolism,
M Gomi, and
S Iida, and
Y Itoh, and
K Moriwaki, and
S Kanayama, and
M Namba, and
S Tarui
May 2003,
Clinical endocrinology,
